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Abstract A novel putative SR protein, designated cisplatin
resistance-associated overexpressed protein (CROP), has been
cloned from cisplatin-resistant cell lines by differential display.
The N-half of the deduced amino acid sequence of 432 amino
acids of CROP contains cysteine/histidine motifs and leucine
zipper-like repeats. The C-half consists mostly of charged and
polar amino acids: arginine (58 residues or 25%), glutamate (36
residues or 16%), serine (35 residues or 15%), lysine (30 residues,
13%), and aspartate (20 residues or 9%). The C-half is extremely
hydrophilic and comprises domains rich in lysine and glutamate
residues, rich in alternating arginine and glutamate residues, and
rich in arginine and serine residues. The arginine/serine-rich
domain is dominated by a series of 8 amino acid imperfect
repetitive motif (consensus sequence, Ser-Arg-Ser-Arg-Asp/Glu-
Arg-Arg-Arg), which has been found in RNA splicing factors.
The RNase protection assay and Western blotting analysis
indicate that the expression of CROP is about 2^3-fold higher in
mRNA and protein levels in cisplatin-resistant ACHN/CDDP
cells than in host ACHN cells. CROP is the human homologue of
yeast Luc7p, which is supposed to be involved in 5P-splice site
recognition and is essential for vegetative growth.
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1. Introduction
cis-Diamminedichloroplatinum (II) (cisplatin) has become
one of the most widely used anticancer drugs targeting a va-
riety of malignant tumors, including those of testes, head and
neck, esophagus, lung, ovary and bladder [1]. However, their
clinical e¡ectiveness is frequently limited by the emergence of
drug-resistant tumor cell populations that are often cross-re-
sistant to structurally unrelated drugs [2,3]. Cisplatin reacts
with DNA to produce 1,2-intrastrand cross-links between ad-
jacent purines. The initial cytotoxic e¡ects of the drug are
believed to be due to an inhibition of DNA synthesis at the
site of adduct formation [4,5]. It is also believed that cisplatin
reacts with RNA to produce adducts [6^8]. They inhibit tran-
scription by interfering with chromatin remodeling, and with
transcription factor binding as well as with RNA synthesis
itself [6]. Furthermore, RNA adducts of cisplatin a¡ect
RNA splicing [9].
Cisplatin resistance could be mediated through various
mechanisms, including inactivation of cisplatin by thiol-con-
taining molecules such as glutathione [10] and metallothionein
[11], increased DNA repair [12], decreased drug accumulation
[13], reduction in total cellular topoisomerase activity [14].
Increased expression of thioredoxin [15] and T-plastin [16]
has also been reported. Because several of these mechanisms
appear to operate in individual resistant cell lines, it is di⁄cult
to set the target for overcoming cisplatin resistance.
To explore a key molecule of cisplatin resistance, we tried
to isolate genes that are commonly overexpressed in several
cisplatin-resistant cell lines. Here, we report that a novel argi-
nine/serine-rich nuclear protein, cisplatin resistance-associated
overexpressed protein (CROP)/hLuc7A, is overexpressed in
cisplatin-resistant cell lines.
2. Materials and methods
2.1. Materials
Cisplatin was obtained from Sigma. [K-32P]CTP was obtained from
Amersham.
2.2. Cell lines
Human renal cancer cells, ACHN and NC65, were propagated in
RPMI 1640 medium with 10% fetal bovine serum under 5% CO2 at
37‡C. Cisplatin-resistant cell lines, ACHN/CDDP and NC65/CDDP,
were established by propagation in the presence of 5 Wg/ml cisplatin
[17].
2.3. Di¡erential display and cDNA cloning
Di¡erential display was done as described [18] by using RNAmap
kit (GenHunter, Brookline, MA, USA). Brie£y, total RNA was re-
verse-transcribed with T12MN oligonucleotides (M = G, C or A;
N = G, A, T or C) as primer. PCR was done with synthesized cDNAs
as templates and with the respective T12MN oligonucleotide and spe-
ci¢c arbitrary 10-mer according to the manufacturer’s directions. PCR
products were analyzed by electrophoresis on 7% sequencing gels and
cloned into pT7Blue T-Vector (Novagen). ACHN/CDDP cDNA li-
brary was made with V SHlox cloning kits (Novagen).
2.4. Reverse transcriptase (RT-) PCR analysis
Total RNA was converted to cDNA by reverse transcriptase and
the cDNA was subjected to PCR (94‡C for denaturation, 50‡C for
annealing, and 72‡C for extension) with human G3PDH control
primers (Clontech) and with CROP primers (5P-ACGTTCTGAT-
CTTGGTCCG-3P and 5P-TCGACGTTGTGGACCTTAGC-3P). Am-
pli¢cation was done for 25 cycles.
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2.5. Cloning of 5P-region of cDNA
The 5P-region of cDNA of the gene was isolated with 5P-Ampli-
¢nder RACE kit (Clontech). The ¢rst strand cDNA synthesis was
done with total RNA from ACHN/CDDP and with an oligonucleo-
tide 5P-CTGCTGCATCTTCTGTCTGATG-3P. After an Ampli¢nder
anchor oligonucleotide was ligated to the 3P-end of cDNA, PCR was
done with an Ampli¢nder anchor primer and an oligonucleotide 5P-
GTGTCTACTTCGTGAACGACTTCTC-3P.
2.6. RNase protection assay
The 162 nucleotide fragment (from 64 to 235 from the translation
start site) was synthesized from the long-type CROP cDNA by PCR
with primers CCCAAGCTTAGCAACGTGCG (HindIII site is
underlined) and CCTGGATCCACTTGTCATCTTCC (BamHI site
is underlined). The PCR products were inserted into pGEM vector.
The plasmid DNA was linearized with HindIII and the antisense
RNA probes were synthesized with T7 RNA polymerase. Total
RNA (35 Wg) was hybridized with 32P-labeled antisense RNA probes.
Products were analyzed by electrophoresis on a 7% sequencing gel.
2.7. Preparation of antibody against CROP
The amino-terminal half of CROP (amino acids 1^245) was fused
with histidine tag in a pET28a vector (Novagen), and the fusion
protein was expressed in Escherichia coli strain BL21. The fusion
protein was puri¢ed with His-bind resin (Novagen), and a rabbit
polyclonal antibody was raised against the puri¢ed protein.
3. Results
3.1. Isolation of cDNAs overexpressed in cisplatin-resistant cell
lines
cDNA fragments, expressed higher in cisplatin-resistant
ACHN/CDDP cells than its host ACHN cells, were isolated
by di¡erential display. Among them, 11 fragments were found
to hybridize with mRNAs overexpressed in ACHN/CDDP by
Northern analysis (data not shown). The isolated fragments
being used as probes, 1.7 kb and 2.6 kb fragments, were iso-
lated from a cDNA library prepared from ACHN/CDDP
mRNAs. The sequence analysis revealed that the 1.7 kb
cDNA encodes plastin. It was reported that the expression
of T-plastin gene is higher in cisplatin-resistant human cancer
cells [16]. This suggested that the di¡erential display in this
study worked.
The PCR analysis suggested that the sequence from the
2.6 kb fragment is overexpressed in cisplatin-resistant cell lines
derived from two di¡erent cell lines, ACHN and NC65 (Fig.
1). Because sequence analysis has suggested that the 2.6 kb
cDNA fragment does not contain the 5P-region of the cDNA,
we did 5P-RACE to isolate the 5P-region. We analyzed several
clones and found that cDNA fragments isolated with
5P-RACE could be divided into two groups. One is about
1240 bp, and the other about 1050 bp. The short-type cDNAs
(about 1050 bp) do not contain a region of 193 bp, which
exists in the long-type cDNAs at 214^406 bases from A in
the ¢rst ATG (Fig. 2A). The 193 bp region contains several
nonsense codons so that the long-type cDNA cannot encode
any long open reading frame. In contrast, the short-type
1.05 kb cDNA, together with the 2.6 kb cDNA fragment,
encodes a long open reading frame of 432 amino acids (Fig.
2A), which we named CROP.
To examine whether the translatable short-type mRNA of
the CROP gene is expressed in the cisplatin-resistant ACHN/
CDDP cells, RNase protection assay was done with a 230
base RNA probe (Fig. 3). This probe contains the 5P-terminal
63 base sequence of the 193 base exon, the 99 base cDNA
sequence adjacent to the 5P-end of the 193 base exon, and a
68 base sequence of vector. Both cisplatin-sensitive ACHN
cells and cisplatin-resistant ACHN/CDDP cells produced
mainly two protected RNA bands of 99 base and 162 base.
The amounts of 99 base and 162 base bands represent the
amounts of the short-type mRNA and the long-type
mRNA, respectively. This indicated that the amount of the
short-type translatable mRNA is about three times more in
cisplatin-resistant ACHN/CDDP cells, and that more than
90% of the CROP mRNA is the short-type mRNA in cispla-
tin-resistant ACHN/CDDP cells.
3.2. Amino acid sequence and domain organizations of CROP
The N-half of the deduced amino acid sequence of CROP
contains cysteine/histidine motifs and leucine zipper-like re-
peats. The C-half of CROP consists mostly of charged and
polar amino acids: arginine (58 residues or 25%), glutamate
(36 residues or 16%), serine (35 residues or 15%), lysine
Fig. 1. RT-PCR analysis. 1, ACHN; 2, cisplatin-resistant ACHN/
CDDP; 3, NC65; 4, cisplatin-resistant NC65/CDDP.
Fig. 2. Predicted amino acid sequence of CROP (A), and schematic
domain organizations of CROP-related genes (B). A: The cysteine/
histidine motifs are underlined once. The leucine zipper-like repeats
are underlined twice. The lysine/glutamate-rich region is underlined
with a dashed line. The arginine/glutamate-rich region is in bold
and underlined letters. The arginine/serine-rich region is in bold let-
ters. 8 Amino acid imperfect repetitive motifs in serine/arginine-rich
domain are in boxes. The arrow head indicates the site in which the
193 base exon is inserted. B: A. thaliana putative arginine-aspartate-
rich RNA binding protein (U78866.1) and C. elegans B0495.8. CH,
cysteine/histidine motifs; L, leucine zipper-like repeats; KE, lysine/
glutamate-rich region; KRE, lysine/arginine/glutamate-rich region;
RD, arginine/serine-rich region; RS, arginine/serine-rich region; b, 8
amino acid imperfect repetitive motif.
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(30 residues or 13%), and aspartate (20 residues or 9%). It is
extremely hydrophilic and comprises domains rich in lysine
and glutamate residues, rich in alternating arginine and glu-
tamate residues, and rich in arginine and serine residues. The
arginine/serine-rich domain (RS domain) is dominated by a
series of 8 amino acid imperfect repetitive motif (consensus
sequence, Ser-Arg-Ser-Arg-Asp/Glu-Arg-Arg-Arg). This motif
has been found in HEL117, an RNA helicase [19], and the
70K component of the U1 snRNP particles [20]. Interestingly,
Arabidopsis thaliana putative arginine-aspartate-rich RNA
binding protein and Caenorhabditis elegans B0495.8 also con-
tain a region rich in lysine and glutamate residues, rich in
alternating arginine and glutamate residues, and rich in argi-
nine and serine residues (Fig. 2B). Domain organizations of
CROP, ATU78866.1 and CELB0495.8 are quite similar.
3.3. Higher expression of CROP in the nucleus of
cisplatin-resistant cells
A 58 kDa protein was detected by the anti-CROP antibody
in the nuclear extract from ACHN host cells and cisplatin-
resistant ACHN/CDDP cells, but not in their cytosolic frac-
tion (Fig. 4B). The amount of 58 kDa protein is about 2-fold
more in ACHN/CDDP cells than ACHN host cells. To con-
¢rm that the 58 kDa protein is CROP, the CROP expression
plasmid was transiently transfected into Cos-7 cells. The anti-
CROP antibody recognized an endogenous 58 kDa protein in
the nuclear extract from Cos-7 cells, and the overexpressed
58 kDa protein in the nuclear extract from the transfected
cells (Fig. 4A). These results indicate that the 58 kDa nuclear
protein is CROP, and that the expression of CROP is higher
in ACHN/CDDP cells than ACHN host cells.
3.4. Expression of CROP mRNA in human tissues
Northern blot analysis indicated that the CROP gene is
expressed in almost all tissues tested as mRNA of about
3.5 kb (Fig. 5). Importantly, the expression of the CROP
gene showed the clear tissue-speci¢city: it is expressed
strongly in heart, brain, pancreas, thymus, ovary, small intes-
tine and peripheral blood leukocyte, and weakly in lung, liver
and kidney.
4. Discussion
We cloned a cDNA for a nuclear protein of 432 amino
acids from cisplatin-resistant ACHN/CDDP cells, and named
this protein CROP. The expression of CROP in mRNA and
protein levels is about 2^3-fold higher in the cisplatin-resistant
cells than the host cisplatin-sensitive cells.
The N-half of CROP contained cysteine/histidine motifs
and leucine zipper-like repeats. The cysteine/histidine motif
in CROP is highly homologous to those in A. thaliana puta-
tive arginine-aspartate-rich RNA binding protein [21] and
other three proteins from C. elegans and Saccharomyces cer-
evisiae. This cysteine/histidine motif (C-X2-C-X13ÿ15-H-X5-H)
is also found in the human snRNP polypeptide C and the
yeast PRP6, PRP9 and PRP11, involved in the nuclear splic-
ing pathway [22]. The C-half of CROP comprises domains
rich in lysine and glutamate residues, rich in alternating argi-
nine and glutamate residues, and rich in arginine and serine
residues (RS domain). The RS domain is dominated by a
series of 8 amino acid imperfect repetitive motif (consensus
Fig. 3. RNase protection assay. The 230 base RNA probe is dia-
gramed at the right. The 5P-terminal 63 base sequence of the 193
base exon is indicated by a black box. The 99 base cDNA sequence
adjacent to the 5P-end of the 193 base exon is indicated by a
hatched box. The 68 base sequence of vector is indicated by an
open box. Lane 1, ACHN; lane 2, ACHN/CDDP. Lower panel,
ethidium bromide staining of 5 Wg total RNA used for the assay.
Fig. 4. Western blotting with the anti-CROP antibody. A: Cytosolic
fraction (lanes 1 and 2) and nuclear extract (lanes 3 and 4) of Cos-7
cells (lanes 1 and 3) and Cos-7 cells transiently expressing CROP
(lanes 2 and 4). B: Cytosolic fraction (lanes 1 and 2) and nuclear
extract (lanes 3 and 4) of ACHN cells (lanes 1 and 3) and ACHN/
CDDP (lanes 2 and 4). Proteins (50 Wg) were separated by electro-
phoresis on a 10% sodium dodecyl sulfate-polyacrylamide gel.
Fig. 5. Expression of CROP mRNA in human tissues. Human mul-
tiple tissue Northern blot I, II (Clontech), containing approximately
2 Wg of poly(A) RNA per lane from the indicated human tissues,
were analyzed by Northern blot hybridization with a CROP-speci¢c
probe. Lane 1, heart; 2, brain; 3, placenta; 4, lung; 5, liver; 6, skel-
etal muscle; 7, kidney; 8, pancreas; 9, spleen; 10, thymus; 11, pros-
tate; 12, testis; 13, ovary; 14, small intestine; 15, colon; 16, periph-
eral blood leukocyte.
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sequence, Ser-Arg-Ser-Arg-Asp/Glu-Arg-Arg-Arg), which has
been found in RNA splicing factors.
The SR proteins, characterized by a C-terminal RS domain
[23^26], are involved in the formation of spliceosome, localize
in a nucleus, and show speckled intranuclear distribution, in
which snRNP particles and SR proteins are suggested to be
organized [27]. Some RS domains are predicted to mediate
protein-protein interactions, to work as a nuclear localization
signal, and formation of spliceosome assembly.
Recently, it was reported that yLuc7p, a novel yeast U1
snRNP protein, is essential for vegetative growth, and that
mutation of yLuc7 causes a defect in pre-mRNA splicing
[28]. yLuc7p is supposed to be involved in the interaction
between U1 snRNP and the nuclear cap binding complex
and in 5P-splice site recognition. The homologues of yLuc7
have been found from the EST data base of higher eukar-
yotes. Interestingly, all metazoan LUC7 family members con-
tain a carboxyl-terminal extension with multiple arginine-ser-
ine (RS) or arginine-glutamate (RE) repeats [28]. The CROP
protein was turned out to be identical to hLuc7A. Higher
expression of CROP could in£uence 5P-splice site recognition
and alternative splicing, which may be directly or indirectly
involved in cisplatin resistance.
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